These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Changing standards of surgical care for the melanoma patient. Reintgen DS Ann Surg Oncol; 1996 Jul; 3(4):327-8. PubMed ID: 8790843 [No Abstract] [Full Text] [Related]
25. Melanoma stem cells--are there devils in the detail? Shackleton M Pigment Cell Melanoma Res; 2010 Oct; 23(5):693-4. PubMed ID: 20704685 [No Abstract] [Full Text] [Related]
26. Melanomas and Mechanical Stress Points on the Plantar Surface of the Foot. Minagawa A; Omodaka T; Okuyama R N Engl J Med; 2016 Jun; 374(24):2404-6. PubMed ID: 27305207 [No Abstract] [Full Text] [Related]
27. Spontaneous partial regression of primary melanoma with death due to metastases. Saida T; Tsuchiya S Arch Dermatol; 1984 Nov; 120(11):1494-6. PubMed ID: 6497418 [TBL] [Abstract][Full Text] [Related]
28. Increase lymphangiogenesis in melanoma during pregnancy: correlation with the prolactin signalling pathway. Rodero MP; Prignon A; Avril MF; Boitier F; Aractingi S; Khosrotehrani K J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e144-5. PubMed ID: 22548459 [No Abstract] [Full Text] [Related]
29. Computer simulation analysis of morphological patterns in human melanocytic skin tumours. Smolle J; Soyer HP; Smolle-Juettner FM; Stettner H; Kerl H Pathol Res Pract; 1991 Dec; 187(8):986-92. PubMed ID: 1792195 [TBL] [Abstract][Full Text] [Related]
30. Loss of primary cilia in melanoma cells is likely independent of proliferation and cell cycle progression. Snedecor ER; Sung CC; Moncayo A; Rothstein BE; Mockler DC; Tonnesen MG; Jones EC; Fujita M; Clark RA; Shroyer KR; Chen J J Invest Dermatol; 2015 May; 135(5):1456-1458. PubMed ID: 25629424 [No Abstract] [Full Text] [Related]
33. Molecular markers of melanocytic tumor progression. Weterman MA; van Muijen GN; Bloemers HP; Ruiter DJ Lab Invest; 1994 May; 70(5):593-608. PubMed ID: 8196357 [No Abstract] [Full Text] [Related]
34. Diffuse cutaneous melanosis in malignant melanoma. Paulo Filho Tde A; da Trindade Neto PB; Reis JC; Bartelt L; da Costa SA Dermatol Online J; 2007 May; 13(2):9. PubMed ID: 17498428 [No Abstract] [Full Text] [Related]
36. Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells. Roesch A; Becker B; Schneider-Brachert W; Hagen I; Landthaler M; Vogt T J Invest Dermatol; 2006 Aug; 126(8):1850-9. PubMed ID: 16645588 [TBL] [Abstract][Full Text] [Related]
37. Beyond ABC: another mechanism of drug resistance in melanoma side population. Fukunaga-Kalabis M; Herlyn M J Invest Dermatol; 2012 Oct; 132(10):2317-2319. PubMed ID: 22971921 [TBL] [Abstract][Full Text] [Related]
38. Asymptomatic, evolving lesion on the upper arm. Menon SK; Usatine RP Am Fam Physician; 2015 Mar; 91(6):389-90. PubMed ID: 25822558 [No Abstract] [Full Text] [Related]
39. Pregnancy and the prognosis of malignant melanoma. Grin CM; Driscoll MS; Grant-Kels JM Semin Oncol; 1996 Dec; 23(6):734-6. PubMed ID: 8970595 [TBL] [Abstract][Full Text] [Related]
40. [Malignant melanoma in café-au-lait spot]. Dücker P; Pfeiff B; Pullmann H Z Hautkr; 1990 Aug; 65(8):751-3. PubMed ID: 2284835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]